|
Field
Last Published
|
Before
July 30, 2019 05:14 PM
|
After
July 30, 2019 05:17 PM
|
|
Field
Intervention (Public)
|
Before
The study was a Single-Blind, Randomized Controlled Trial comparing psychological intervention group, based on Transdiagnostic therapy principles, with a control group. The statistical population consisted of all females with MS living in Capital and around. First, a group of 400 females with MS who officially registered in MS clinics from October 2010 to October 2016, was selected. They invited over telephone, emails, and were notified about a summary of the objectives of the study,
|
After
The study was a Single-Blind, Randomized Controlled Trial comparing psychological intervention group, based on Transdiagnostic therapy principles, with a control group. The statistical population consisted of all females with MS living in Capital and around. First, a group of 400 females with MS who officially registered in MS clinics from October 2010 to October 2016, was selected. They invited over telephone, emails, and were notified about a summary of the objectives of the study.
|
|
Field
Experimental Design (Public)
|
Before
The inclusion criteria included:
1. Diagnosis of MS for three years or more
2. Fluent in Persian, at least 18 years of age
4. Received at least one current diagnostic of a valid depression disorder and an anxiety disorder on Structural Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth. Edition Axis I Disorders.
5. Received at least one self-report score without the cut-off range specified for screening measure, Anxiety Severity and Impairment Scale (OASIS), ODSIS, the Geriatric Depression Scale, the Penn State Worry Questionnaire (PSWQ), in addition to, Received at least one self-report score without the cut-off range specified for emotional screening measure :
Difficulties in Emotion Regulation Scale (DERS), the Positive and Negative Affect Schedule (PANAS), the Southampton Mindfulness Questionnaire (SMQ), and Emotion Regulation Questionnaire (ERQ-R).
5. Willing to participate in the research.
6. Fill and signature consent
7. Medical MS agreement for participation
The motive element plays an essential role in this treatment due to the relative difficulty of this treatment method. Therefore, this treatment was administered to those who were conscious of the content of this therapy and motivated to cope with its challenges.
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or lactation,
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history or drug dependence except for nicotine
7. Absenteeism for more than three sessions
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|
After
The inclusion criteria included:
1. Diagnosis of MS for three years or more
2. Fluent in Persian, at least 18 years of age
4. Received at least one current diagnostic of a valid depression disorder and an anxiety disorder on Structural Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth. Edition Axis I Disorders.
5. Received at least one self-report score without the cut-off range specified for screening measureS
5. Willing to participate in the research.
6. Fill and signature consent
7. Medical agreement for participation
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or lactation,
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history or drug dependence except for nicotine
7. Absenteeism for more than three sessions
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|
|
Field
Sample size (or number of clusters) by treatment arms
|
Before
The sample size was calculated using the Cohen formula to measure the effectiveness of the interven0tion (32). Taking into account the confidence of 0.95 and the test power of .90, the results of this formula showed that 26 people are required per group. Given the probability of quitting the research and the available options, this paper was conducted on two groups of 32persons (in a total of 64 people) selected using the purposeful sampling method.
At last, 64 patients, met all inclusion criteria, were assigned to treatment and control groups using computer-generated random numbers.
|
After
The sample size was calculated using G-POWER
|